Functioned as an advisor and subject matter expert on the MPSMS data source, as part of a larger project to better understand and effectively address factors contributing to disparities related to adverse drug events.

Challenge:

Preventable Adverse Drug Events (ADEs) have a significant impact on patient lives and the cost of care. Over 770,000 people are injured or die each year in hospitals from adverse drug events (ADEs), which may cost up to $5.6 million each year per hospital depending on hospital size.

Solution:

The Centers for Medicare and Medicaid Services (CMS), in partnership with Office of the Assistant Secretary for Health/Office of Disease Prevention and Health Promotion (OASH/ODPHP), and the MITRE Corporation, partnered with hospitals and hospital networks to perform a root cause analysis designed to better understand and effectively address factors contributing to disparities related to ADEs. Qualidigm functioned as an advisor and subject matter expert on the MPSMS data source, the largest and most robust patient safety database in the world, for the MITRE OASH Disparities Analytics team.

Benefit:

As a result of Qualidigm’s expertise, the MITRE team was able to more effectively analyze and interpret the data for the hospital disparities project.

Qualidigm has provided analytic support, technical assistance and leadership for over to 200 patient safety studies and has supported the manuscript writing process for related publications for MPSMS Publication Groups, including a paper on trends in adverse events published in the New England Journal of Medicine.